Comparison of specific ovarian tumor markers by elecsys analyzer 2010

about

Genomic markers of ovarian adenocarcinoma and its relevancy to the effectiveness of chemotherapy.A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.

P2860

Q41615733-E6758BBB-1267-4750-A7EF-017B52C427D3 Q47128416-66080198-71A2-43B6-8E40-6F72A7051783

P2860

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

Item

http://www.wikidata.org/entity/Q35601405

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

@ast

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

@en

type

Item

label

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

@ast

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

@en

prefLabel

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

@ast

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

@en

P1476

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

@en

P2093

Lejla Hasanbegovic

http://www.w3.org/2001/XMLSchema#string

Nedeljka Sljivo

http://www.w3.org/2001/XMLSchema#string

Selma Alicelebic

http://www.w3.org/2001/XMLSchema#string

P2860

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

CA125 immune complexes in ovarian cancer patients with low CA125 concentrations.

Current state of biomarker development for clinical application in epithelial ovarian cancer.

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

Cancer antigen 125 and prognosis.

Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders.

Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review.

P304

86-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5455/AIM.2015.23.86-89

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276115161

http://www.w3.org/2001/XMLSchema#string

P698

26005273

http://www.w3.org/2001/XMLSchema#string

P932

4430012

http://www.w3.org/2001/XMLSchema#string

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

about

P2860

P2860

Comparison of specific ovarian tumor markers by elecsys analyzer 2010

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932